Industries We Serve with Our Market Access, Quality Compliance & Regulatory Affairs Consulting Services

Cisema provides trusted regulatory affairs consulting services to help companies succeed across the Asia Pacific region. With deep expertise in China and the Hong Kong SAR, and expanding support across Southeast Asia and Taiwan, we work with clients in diverse regulatory environments. Backed by decades of experience in regulatory affairs consulting, our team of regulatory experts delivers comprehensive regulatory services, providing end-to-end support for compliance and approvals. We have a proven track record of achieving successful regulatory outcomes for medical devices, IVDs, pharmaceuticals, cosmetics, health products, consumer goods, and industrial products. Our expert guidance ensures smooth market entry, regulatory compliance, and long-term success in one of the world’s most dynamic regions.

Two men in business suits sitting at a table engaged in a meeting with a third person.
Regulatory submissions

Industries We Serve

We support companies in over 16 regulated industries, with a focus on streamlining compliance and approvals for our clients. We help them meet the evolving regulatory landscape and compliance requirements, accelerate approvals, and maintain product quality throughout the lifecycle. For each industry, we develop a tailored regulatory strategy and identify the optimal regulatory pathway to ensure efficient progression through approval stages and reduce risks.

Medical Devices

We assist manufacturers with product registration, clinical trials, post-market surveillance, quality control, and the implementation of quality management systems. As well as inspection and sourcing services, in China, Hong Kong and Taiwan and across Southeast Asia.

Learn more

In Vitro Diagnostics (IVDs)

Our team helps IVD companies navigate rigorous clinical validation, registration, and post-market requirements, ensuring compliance with the latest regulatory and clinical guidelines. We also deliver quality control, inspection, and sourcing services across China, Hong Kong, Taiwan and Southeast Asia.

Learn more

Pharmaceuticals

From early development through to commercialization, we support drug manufacturers throughout the entire drug development process, providing strategic guidance, submission support, and GMP alignment for success across Asia Pacific.Our team has extensive expertise in the preparation and submission of drug applications, including ANDAs and NDAs, ensuring regulatory compliance and smooth interactions with agencies.

Learn more

Biotech

We provide regulatory guidance for biotech innovators across Asia Pacific, supporting clinical trial design, biosafety clearance, import licensing, and alignment with regulators' expectations.

Learn more

Cosmetics & Ingredients

We support cosmetic and ingredient manufacturers throughout the full product lifecycle in China and Taiwan from pre-registration or notification to post-market. We are your “Responsible Person” and ensure quality compliance with Chinese and Taiwanese regulations, assisting in preparation for NMPA and TFDA audits as required.

Learn more

Health Foods & Supplements

We handle regulatory strategies, raw material approvals, testing, and registrations for dietary supplements and health foods. Our team ensures quality compliance and smooth market entry.

Learn more

Veterinary Drugs & Pet Food

We support MARA interactions, registration, licensing, and testing for pet foods and veterinary medicinal products entering the Chinese market.

Learn more

Industrial Goods & Consumer Products

We help you get your products on the market faster, from electronics and toys to machinery, telecom, and automotive parts. Our team manages CCC, HAF 604, CML, CEL, RoHS, NAL, SRRC, and more. From testing and documentation to renewals and authority approvals, we streamline every step to ensure full compliance with China’s regulations.

Learn more

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Why Work with Cisema

Latest Insights

View More

China Tightens Medical Device Post-Market Surveillance with New Risk Evaluation and Report Review Rules

China issues new guidelines on medical device adverse event risk evaluation and periodic report review, tightening post-market surveillance requirements

April 27, 2026
China Tightens Medical Device Post-Market Surveillance with New Risk Evaluation and Report Review Rules
Clinician adjusts IV pump in hospital room while colleague records data, illustrating medical device use and compliance.

New NMPA Guideline Defines Registration Requirements for IVUS Systems and Catheters

China’s CMDE releases a new IVUS registration review guideline, defining technical, clinical, and testing requirements for NMPA medical device registration

April 27, 2026
New NMPA Guideline Defines Registration Requirements for IVUS Systems and Catheters

Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices

Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements

April 23, 2026
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Two professionals in an office review documentation for a HealthScreen glucose monitor while examining a computer display showing a product label with model number, barcode, and QR code. One person points to the code on the screen as the other reads.

Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens

Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.

April 23, 2026
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Two office professionals sit at a desk in an office reviewing cosmetic and skincare product packaging alongside printed documents and binders. One person examines a product bottle while the other works on a laptop, suggesting regulatory compliance review.

BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation

BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.

April 23, 2026
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
Laboratory scientist wearing a lab coat, protective goggles, gloves, and a blue hair cover carefully examining a small vial of liquid in a modern laboratory. A tray of sample vials sits on the bench in front.

China NMPA Issues 26 Medical Device Standards Affecting Orthopedics, IVDs, & Software

The 26 new medical device standards cover orthopedic implants, IVDs, active devices, and software risk management.

April 23, 2026
China NMPA Issues 26 Medical Device Standards Affecting Orthopedics, IVDs, & Software
Previous
Previous

Get in Touch with Our Regulatory Affairs Experts

And discover how we can support you across your various projects in Asia Pacific.

Request Proposal